ABCA1 Expression and Statins: Inhibitory Effect in Peripheral Blood Mononuclear Cells

• Tall AR : Cholesterol efflux pathways and other potential mechanisms involved in the athero-protective effect of high density lipoproteins.J. Intern. Med.263(3) , 256–273 (2008).
   PubMed Web of Science ®Google Scholar
• Hersberger M , von Eckardstein A: Low high-density lipoprotein cholesterol: physiological background, clinical importance and drug treatment. Drugs63(18) , 1907–1945 (2003).
   PubMed Web of Science ®Google Scholar
• Krimbou L , MarcilM, GenestJ: New insights into the biogenesis of human high-density lipoproteins.Curr. Opin. Lipidol.17(3) , 258–267 (2006).
   PubMed Web of Science ®Google Scholar
• Cavigiolio G , ShaoB, GeierEG, RenG, HeineckeJW, OdaMN: The interplay between size, morphology, stability, and functionality of high-density lipoprotein subclasses.Biochemistry47(16) , 4770–4779 (2008).
   PubMed Web of Science ®Google Scholar
• Timmins JM , LeeJY, BoudyguinaE et al.: Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of ApoA-I.J. Clin. Invest.115(5) , 1333–1342 (2005).
   PubMed Web of Science ®Google Scholar
• Francone OL , SubbaiahPV, van Tol A, Royer L, Haghpassand M: Abnormal phospholipid composition impairs HDL biogenesis and maturation in mice lacking Abca1. Biochemistry42(28) , 8569–8578 (2003).
   PubMed Web of Science ®Google Scholar
• Calpe-Berdiel L , RotllanN, PalomerX, RibasV, Blanco-VacaF, Escolà-GilJC: Direct evidence in vivo of impaired macrophage-specific reverse cholesterol transport in ATP-binding cassette transporter A1-deficient mice.Biochim. Biophys. Acta1738(1–3) , 6–9 (2005).
   PubMed Web of Science ®Google Scholar
• Oram JF , HeineckeJW: ATP-binding cassette transporter A1: a cell cholesterol exporter that protects against cardiovascular disease.Physiol. Rev.85(4) , 1343–1372 (2005).
   PubMed Web of Science ®Google Scholar
• Lee JY , ParksJS: ATP-binding cassette transporter AI and its role in HDL formation.Curr. Opin. Lipidol.16(1) , 19–25 (2005).
   PubMed Web of Science ®Google Scholar
• Brunham LR , KruitJK, IqbalJ et al.: Intestinal ABCA1 directly contributes to HDL biogenesis in vivo.J. Clin. Invest.116(4) , 1052–1062 (2006).
   PubMed Web of Science ®Google Scholar
• Nofer JR , RemaleyAT: Tangier disease: still more questions than answers.Cell. Mol. Life Sci.62(19–20) , 2150–2160 (2005).
   PubMed Web of Science ®Google Scholar
• Bodzioch M , OrsóE, KluckenJ et al.: The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease.Nat. Genet.22(4) , 347–351 (1999).
   PubMed Web of Science ®Google Scholar
• Brooks-Wilson A , MarcilM, CleeSM et al.: Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency.Nat. Genet.22(4) , 336–345 (1999).
   PubMed Web of Science ®Google Scholar
• Marcil M , Brooks-WilsonA, CleeSM et al.: Mutations in the ABC1 gene in familial HDL deficiency with defective cholesterol efflux.Lancet354(9187) , 1341–1346 (1999).
   PubMed Web of Science ®Google Scholar
• Rust S , RosierM, FunkeH et al.: Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1.Nat. Genet.22(4) , 352–355 (1999).
   PubMed Web of Science ®Google Scholar
• Orsó E , BroccardoC, KaminskiWE et al.: Transport of lipids from golgi to plasma membrane is defective in tangier disease patients and Abc1-deficient mice.Nat. Genet.24(2) , 192–196 (2000).
   PubMed Web of Science ®Google Scholar
• McNeish J , AielloRJ, GuyotD et al.: High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1.Proc. Natl Acad. Sci. USA97(8) , 4245–4250 (2000).
   PubMed Web of Science ®Google Scholar
• Joyce C , FreemanL, BrewerHB Jr, Santamarina-Fojo S: Study of ABCA1 function in transgenic mice. Arterioscler. Thromb. Vasc. Biol.23(6) , 965–971 (2003).
   PubMed Web of Science ®Google Scholar
• Vaisman BL , LambertG, AmarM et al.: ABCA1 overexpression leads to hyperalphalipoproteinemia and increased biliary cholesterol excretion in transgenic mice.J. Clin. Invest.108(2) , 303–309 (2001).
   PubMed Web of Science ®Google Scholar
• Dean M , HamonY, ChiminiG: The human ATP-binding cassette (ABC) transporter superfamily.J. Lipid Res.42(7) , 1007–1017 (2001).
   PubMed Web of Science ®Google Scholar
• Santamarina-Fojo S , PetersonK, KnapperC et al.: Complete genomic sequence of the human ABCA1 gene: analysis of the human and mouse ATP-binding cassette A promoter.Proc. Natl Acad. Sci. USA97(14) , 7987–7992 (2000).
   PubMed Web of Science ®Google Scholar
• Luciani MF , DenizotF, SavaryS, MatteiMG, ChiminiG: Cloning of two novel ABC transporters mapping on human chromosome 9.Genomics21(1) , 150–159 (1994).
   PubMed Web of Science ®Google Scholar
• Kielar D , DietmaierW, LangmannT et al.: Rapid quantification of human ABCA1 mRNA in various cell types and tissues by real-time reverse transcription-PCR.Clin. Chem.47(12) , 2089–2097 (2001).
   PubMed Web of Science ®Google Scholar
• Wójcicka G , Jamroz-WisniewskaA, HoroszewiczK, BeltowskiJ: Liver X receptors (LXRs). Part I: structure, function, regulation of activity, and role in lipid metabolism.Postepy Hig. Med. Dosw.61 , 736–759 (2007).
   Google Scholar
• Schmitz G , LangmannT: Transcriptional regulatory networks in lipid metabolism control ABCA1 expression.Biochim. Biophys. Acta1735(1) , 1–19 (2005).
   PubMed Web of Science ®Google Scholar
• Singaraja RR , BocherV, JamesER et al.: Human ABCA1 BAC transgenic mice show increased high density lipoprotein cholesterol and ApoAI-dependent efflux stimulated by an internal promoter containing liver X receptor response elements in intron 1.J. Biol. Chem.276(36) , 33969–33979 (2001).
   PubMed Web of Science ®Google Scholar
• Kyriakou T , HodgkinsonC, PontefractDE et al.: Genotypic effect of the -565C>T polymorphism in the ABCA1 gene promoter on ABCA1 expression and severity of atherosclerosis.Arterioscler. Thromb. Vasc. Biol.25(2) , 418–423 (2005).
   PubMed Web of Science ®Google Scholar
• Lutucuta S , BallantyneCM, ElghannamH, GottoAM Jr, Marian AJ: Novel polymorphisms in promoter region of ATP binding cassette transporter gene and plasma lipids, severity, progression, and regression of coronary atherosclerosis and response to therapy. Circ. Res.88(9) , 969–973 (2001).
   PubMed Web of Science ®Google Scholar
• Hodoglugil U , WilliamsonDW, HuangY, MahleyRW: Common polymorphisms of ATP binding cassette transporter A1, including a functional promoter polymorphism, associated with plasma high density lipoprotein cholesterol levels in Turks.Atherosclerosis183(2) , 199–212 (2005).
   PubMed Web of Science ®Google Scholar
• Zwarts KY , CleeSM, ZwindermanAH et al.: ABCA1 regulatory variants influence coronary artery disease independent of effects on plasma lipid levels.Clin. Genet.61(2) , 115–125 (2002).
   PubMed Web of Science ®Google Scholar
• Tan JH , LowPS, TanYS et al.: ABCA1 gene polymorphisms and their associations with coronary artery disease and plasma lipids in males from three ethnic populations in Singapore.Hum. Genet.113(2) , 106–117 (2003).
   PubMed Web of Science ®Google Scholar
• Porchay-Baldérelli I , PéanF, EmeryN et al.: Relationships between common polymorphisms of adenosine triphosphate-binding cassette transporter A1 and high-density lipoprotein cholesterol and coronary heart disease in a population with type 2 diabetes mellitus.Metabolism58(1) , 74–79 (2009).
   PubMed Web of Science ®Google Scholar
• Vaughan CJ , GottoAM Jr: Update on statins: 2003. Circulation110(7) , 886–892 (2004).
   PubMed Web of Science ®Google Scholar
• Gotto AM Jr: Review of primary and secondary prevention trials with lovastatin, pravastatin, and simvastatin. Am. J. Cardiol.96(5A) , 34F–38F (2005).
   PubMed Web of Science ®Google Scholar
• Grundy SM , CleemanJI, MerzCN et al.: Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.J. Am. Coll. Cardiol.44(3) , 720–732 (2004).
   PubMedGoogle Scholar
• Kapur NK , MusunuruK: Clinical efficacy and safety of statins in managing cardiovascular risk.Vasc. Health Risk Manag.4(2) , 341–353 (2008).
   PubMedGoogle Scholar
• LaRosa JC , HeJ, VupputuriS: Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials.JAMA282(24) , 2340–2346 (1999).
   PubMed Web of Science ®Google Scholar
• Wang CY , LiuPY, LiaoJK: Pleiotropic effects of statin therapy: molecular mechanisms and clinical results.Trends Mol. Med.14(1) , 37–44 (2008).
   PubMed Web of Science ®Google Scholar
• Basso F , FreemanL, KnapperCL et al.: Role of the hepatic ABCA1 transporter in modulating intrahepatic cholesterol and plasma HDL cholesterol concentrations.J. Lipid Res.44(2) , 296–302 (2003).
   PubMed Web of Science ®Google Scholar
• Haghpassand M , BourassaPA, FranconeOL, AielloRJ: Monocyte/macrophage expression of ABCA1 has minimal contribution to plasma HDL levels.J. Clin. Invest.108(9) , 1315–1320 (2001).
   PubMed Web of Science ®Google Scholar
• Aiello RJ , BreesD, BourassaPA et al.: Increased atherosclerosis in hyperlipidemic mice with inactivation of ABCA1 in macrophages.Arterioscler. Thromb. Vasc. Biol.22(4) , 630–637 (2002).
   PubMed Web of Science ®Google Scholar
• Zanotti I , FavariE, SpositoAC, RothblatGH, BerniniF: Pitavastatin increases ABCA1-mediated lipid efflux from Fu5AH rat hepatoma cells.Biochem. Biophys. Res. Commun.321(3) , 670–674 (2004).
   PubMed Web of Science ®Google Scholar
• Sone H , ShimanoH, ShuM et al.: Statins downregulate ATP-binding-cassette transporter A1 gene expression in macrophages.Biochem. Biophys. Res. Commun.316(3) , 790–794 (2004).
   PubMed Web of Science ®Google Scholar
• Maejima T , YamazakiH, AokiT et al.: Effect of pitavastatin on apolipoprotein A-I production in HepG2 cell.Biochem. Biophys. Res. Commun.324(2) , 835–839 (2004).
   PubMed Web of Science ®Google Scholar
• Ando H , TsuruokaS, YamamotoH, TakamuraT, KanekoS, FujimuraA: Effects of pravastatin on the expression of ATP-binding cassette transporter A1.J. Pharmacol. Exp. Ther.311(1) , 420–425 (2004).
   PubMed Web of Science ®Google Scholar
• Tamehiro N , Shigemoto-MogamiY, KakeyaT et al.: Sterol regulatory element-binding protein-2- and liver X receptor-driven dual promoter regulation of hepatic ABC transporter A1 gene expression: mechanism underlying the unique response to cellular cholesterol status.J. Biol. Chem.282(29) , 21090–21099 (2007).
   PubMed Web of Science ®Google Scholar
• Wong J , QuinnCM, BrownAJ: Statins inhibit synthesis of an oxysterol ligand for the liver X receptor in human macrophages with consequences for cholesterol flux.Arterioscler. Thromb. Vasc. Biol.24(12) , 2365–2371 (2004).
   PubMed Web of Science ®Google Scholar
• Qiu G , HillJS: Atorvastatin inhibits ABCA1 expression and cholesterol efflux in THP-1 macrophages by an LXR-dependent pathway.J. Cardiovasc. Pharmacol.51(4) , 388–395 (2008).
   PubMed Web of Science ®Google Scholar
• Wong J , QuinnCM, GelissenIC, JessupW, BrownAJ: The effect of statins on ABCA1 and ABCG1 expression in human macrophages is influenced by cellular cholesterol levels and extent of differentiation.Atherosclerosis196(1) , 180–189 (2008).
   PubMed Web of Science ®Google Scholar
• Argmann CA , EdwardsJY, SawyezCG et al.: Regulation of macrophage cholesterol efflux through hydroxymethylglutaryl-CoA reductase inhibition: a role for RhoA in ABCA1-mediated cholesterol efflux.J. Biol. Chem.280(23) , 22212–22221 (2005).
   PubMed Web of Science ®Google Scholar
• Wong J , QuinnCM, GelissenIC, BrownAJ: Endogenous 24(S),25-epoxycholesterol fine-tunes acute control of cellular cholesterol homeostasis.J. Biol. Chem.283(2) , 700–707 (2008).
   PubMed Web of Science ®Google Scholar
• Parini P , GustafssonU, DavisMA et al.: Cholesterol synthesis inhibition elicits an integrated molecular response in human livers including decreased ACAT2.Arterioscler. Thromb. Vasc. Biol.28(6) , 1200–1206 (2008).
   PubMed Web of Science ®Google Scholar
• Guan JZ , TamasawaN, MurakamiH et al.: HMG-CoA reductase inhibitor, simvastatin improves reverse cholesterol transport in Type 2 diabetic patients with hyperlipidemia.J. Atheroscler. Thromb.15(1) , 20–25 (2008).
   PubMed Web of Science ®Google Scholar
• Genvigir FD , SoaresSA, HirataMH et al.: Effects of ABCA1 SNPs, including the C-105T novel variant, on serum lipids of Brazilian individuals.Clin. Chim. Acta389(1–2) , 79–86 (2008).
   PubMed Web of Science ®Google Scholar
• Llaverias G , RebolloA, PouJ et al.: Effects of rosiglitazone and atorvastatin on the expression of genes that control cholesterol homeostasis in differentiating monocytes.Biochem. Pharmacol.71(5) , 605–614 (2006).
   PubMed Web of Science ®Google Scholar
• Langmann T , LiebischG, MoehleC et al.: Gene expression profiling identifies retinoids as potent inducers of macrophage lipid efflux.Biochim. Biophys. Acta1740(2) , 155–161 (2005).
   PubMed Web of Science ®Google Scholar
• Wellington CL , WalkerEK, SuarezA et al.: ABCA1 mRNA and protein distribution patterns predict multiple different roles and levels of regulation.Lab. Invest.82(3) , 273–283 (2002).
   PubMed Web of Science ®Google Scholar
• Oram JF , VaughanAM: ATP-binding cassette cholesterol transporters and cardiovascular disease.Circ. Res.99(10) , 1031–1043 (2006).
   PubMed Web of Science ®Google Scholar
• Llaverias G , LacasaD, ViñalsM et al.: Reduction of intracellular cholesterol accumulation in THP-1 macrophages by a combination of rosiglitazone and atorvastatin.Biochem. Pharmacol.68(1) , 155–163 (2004).
   PubMed Web of Science ®Google Scholar
• Zanotti I , PotìF, FavariE, SteffensenKR, GustafssonJA, BerniniF: Pitavastatin effect on ATP binding cassette A1-mediated lipid efflux from macrophages: evidence for liver X receptor (LXR)-dependent and LXR-independent mechanisms of activation by cAMP.J. Pharmacol. Exp. Ther.317(1) , 395–401 (2006).
   PubMed Web of Science ®Google Scholar
• van Eck M , BosIS, KaminskiWE et al.: Leukocyte ABCA1 controls susceptibility to atherosclerosis and macrophage recruitment into tissues.Proc. Natl Acad. Sci. USA99(9) , 6298–6303 (2002).
   PubMed Web of Science ®Google Scholar
• World Health Organization: Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ. Tech. Rep. Ser.894(i–xii) , 1–253 (2000).
   Web of Science ®Google Scholar
• Rebecchi IM , RodriguesAC, AraziSS et al.: ABCB1 and ABCC1 expression in peripheral mononuclear cells is influenced by gene polymorphisms and atorvastatin treatment.Biochem. Pharmacol.77(1) , 66–75 (2009).
   PubMed Web of Science ®Google Scholar
• Arazi SS , GenvigirFD, WillrichMA et al.: Atorvastatin effects on SREBF1a and SCAP gene expression in mononuclear cells and its relation with lowering-lipids response.Clin. Chim. Acta393(2) , 119–124 (2008).
   PubMed Web of Science ®Google Scholar
• Vandesompele J , De Preter K, Pattyn F et al.: Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol.3(7) , research0034 (2002).
   PubMedGoogle Scholar
• Livak KJ , SchmittgenTD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-δ δ C[T]) method.Methods25(4) , 402–408 (2001).
   PubMed Web of Science ®Google Scholar

▪ Website

• GeNorm normalization of real-time PCR expression data www.medgen.ugent.be/∼jvdesomp/genorm/
   Google Scholar